Comparative evaluation of two methods for studies of experimental focal ischemia: Magnetic resonance tomography and triphenyltetrazoleum detection of brain injuries

Bulletin of Experimental Biology and Medicine

Volumn 147, Issue 2, 2009, Pages 269-272

  Silachev, D N ^a   Uchevatkin, A A ^b   Pirogov, Yu A ^b   Zorov, D B ^a   Isaev, N K ^a  

^a A N Belozyorsky Institute of Physicochemical Biology   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Cerebral ischemia; Magnetic resonance tomography; Triphenyltetrazoleum chloride

Indexed keywords

TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; MAGNETIC RESONANCE TOMOGRAPHY; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; SENSORIMOTOR FUNCTION; STAINING; WEIGHT REDUCTION;

ANIMALS; BRAIN ISCHEMIA; MAGNETIC RESONANCE IMAGING; MALE; RATS; TETRAZOLIUM SALTS;

ANIMALIA;

EID: 67649647899     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-009-0489-z     Document Type: Article

References (13)

1. V. P. Chekhonin, S. V. Lebedev, S. V. Petrov, et al., Byull. Eksp. Biol. Med., 135, No. 6, 629-633 (2003).
2. F. C. Barone, R. K. Clark, G. Feuerstein, et al., Brain Res. Bull., 26, No. 2, 285-291 (1991).
3. J. B. Bederson, L. H. Pitts, S. M. Germano, et al., Stroke, 17, No. 6, 1304-1308 (1986).
4. S. Chandra, R. F. White, D. Everding, et al., Pharmacology, 58, No. 6, 292-299 (1999).
5. U. Dirnagl, C. Iadecola, and M. A. Moskowitz, Trends Neurosci., 22, No. 9, 391-397 (1999).
6. A. J. Hunter, A. R. Green, and A. J. Cross, Trends Pharmacol. Sci., 16, No. 4, 123-128 (1995).
7. J. Jolkkonen, K. Puurunen, S. Rantakomi, et al., Eur. J. Pharmacol., 400, Nos. 2-3, 211-219 (2000).
8. J. Koizumi, Y. Yoshida, T. Nakazawa, et al., Jpn. J. Stroke, 8, 1-8 (1986).
9. S. C. Lenhard, R. Strittmatter, W. J. Price, et al., Pharmacology, 81, No. 1, 1-10 (2008).
10. P. Lipton, Physiol. Rev., 79, No. 4, 1431-1568 (1999).
11. E. Z. Longa, P. R. Weinstein, S. Carlson, and R. Cummins, Stroke, 20, No. 1, 84-91 (1989).
12. T. Schallert, S. M. Fleming, J. L. Leasure, et al., Neuropharmacology, 39, No. 5, 777-787 (2000).
13. N. Shimamura, G. Matchett, T. Tsubokawa, et al., J. Neurosci. Methods, 156, Nos. 1-2, 161-165 (2006).